Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Frontiers in Pharmacology Year : 2021

Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders

Abstract

Metabolic disorders are an increasing concern in the industrialized world. Current research has shown a direct link between the composition of the gut microbiota and the pathogenesis of obesity and diabetes. In only a few weeks, an obesity-inducing diet can lead to increased gut permeability and microbial dysbiosis, which contributes to chronic inflammation in the gut and adipose tissues, and to the development of insulin resistance. In this review, we examine the interplay between gut inflammation, insulin resistance, and the gut microbiota, and discuss how some probiotic species can be used to modulate gut homeostasis. We focus primarily on Faecalibacterium prausnitzii, a highly abundant butyrate-producing bacterium that has been proposed both as a biomarker for the development of different gut pathologies and as a potential treatment due to its production of anti-inflammatory metabolites.
Fichier principal
Vignette du fichier
Possible Benefits of Faecalibacterium -Tatiani Uceli Maioli-2021.pdf (1.26 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03665308 , version 1 (11-05-2022)

Licence

Attribution

Identifiers

Cite

Tatiani Maioli, Esther Borras-Nogues, Licia Torres, Sara Barbosa, Vinicius Martins, et al.. Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders. Frontiers in Pharmacology, 2021, 12, pp.740636. ⟨10.3389/fphar.2021.740636⟩. ⟨hal-03665308⟩
27 View
59 Download

Altmetric

Share

Gmail Facebook X LinkedIn More